Veraxa Biotech Holding AG (VRXA) Non-Current Debt (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Non-Current Debt came in at $3.6 million in Q4 2025, up 51.32% year-on-year from $2.4 million in Q4 2024, and up 51.32% on a QoQ basis from $2.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Non-Current Debt (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Non-Current Debt data on file, last reported at $3.6 million in Q4 2025.
- On a quarterly basis, Non-Current Debt rose 51.32% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $3.6 million, a 51.32% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 51.32% from the prior year.
- Non-Current Debt for Q4 2025 stood at $3.6 million, up from $2.4 million in the prior quarter.
- Over the last five years, Non-Current Debt for VRXA reached as high as $3.6 million in Q4 2025 and fell as low as $2.4 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 2.40 Mn |